Bio-Rad Laboratories ROA 2010-2022 | BIO.B

Current and historical return on assets (ROA) values for Bio-Rad Laboratories (BIO.B) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Bio-Rad Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-06-30 $-1.94B $12.68B -12.00%
2022-03-31 $-0.10B $14.37B -0.61%
2021-12-31 $4.25B $17.78B 25.43%
2021-09-30 $6.66B $19.95B 42.97%
2021-06-30 $4.05B $15.12B 29.94%
2021-03-31 $4.10B $13.93B 33.43%
2020-12-31 $3.81B $12.97B 34.78%
2020-09-30 $3.52B $12.02B 36.28%
2020-06-30 $1.95B $10.10B 22.92%
2020-03-31 $1.58B $8.68B 20.04%
2019-12-31 $1.76B $8.01B 23.68%
2019-09-30 $0.38B $7.18B 5.51%
2019-06-30 $0.90B $7.65B 13.47%
2019-03-31 $0.57B $6.86B 8.96%
2018-12-31 $0.37B $5.61B 5.86%
2018-09-30 $1.28B $6.72B 21.65%
2018-06-30 $1.03B $6.39B 19.56%
2018-03-31 $0.77B $6.22B 16.30%
2017-12-31 $0.12B $4.27B 2.95%
2017-09-30 $0.02B $4.19B 0.40%
2017-06-30 $0.01B $4.14B 0.30%
2017-03-31 $0.03B $3.95B 0.64%
2016-12-31 $0.03B $3.85B 0.65%
2016-09-30 $0.09B $4.02B 2.45%
2016-06-30 $0.09B $3.88B 2.48%
2016-03-31 $0.10B $3.75B 2.81%
2015-12-31 $0.11B $3.71B 3.06%
2015-09-30 $0.10B $3.67B 2.94%
2015-06-30 $0.10B $3.53B 2.86%
2015-03-31 $0.10B $3.33B 2.99%
2014-12-31 $0.09B $3.34B 2.64%
2014-09-30 $0.08B $3.39B 2.37%
2014-06-30 $0.06B $3.47B 1.83%
2014-03-31 $0.07B $3.44B 1.91%
2013-12-31 $0.08B $3.39B 2.29%
2013-09-30 $0.09B $3.28B 2.66%
2013-06-30 $0.14B $3.48B 4.12%
2013-03-31 $0.15B $3.46B 4.61%
2012-12-31 $0.17B $3.44B 5.04%
2012-09-30 $0.18B $3.30B 5.71%
2012-06-30 $0.19B $3.17B 5.96%
2012-03-31 $0.18B $3.19B 5.76%
2011-12-31 $0.18B $3.10B 5.96%
2011-09-30 $0.19B $2.97B 6.24%
2011-06-30 $0.19B $3.04B 6.36%
2011-03-31 $0.18B $2.91B 6.58%
2010-12-31 $0.19B $3.06B 6.88%
2010-09-30 $0.16B $2.68B 6.06%
2010-06-30 $0.15B $2.53B 5.95%
2010-03-31 $0.15B $2.55B 6.06%
2009-12-31 $0.15B $2.54B 6.23%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.412B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $160.059B 9.71
GSK (GSK) United Kingdom $81.408B 9.78
QIAGEN (QGEN) Netherlands $11.018B 18.45
Biohaven Pharmaceutical Holding (BHVN) United States $10.535B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.561B 0.00
Arcus Biosciences (RCUS) United States $1.821B 35.53
Myovant Sciences (MYOV) United Kingdom $1.600B 0.00
Emergent Biosolutions (EBS) United States $1.482B 8.59
Zymeworks (ZYME) Canada $0.390B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Gelesis Holdings (GLS) United States $0.104B 0.00
SQZ Biotechnologies (SQZ) United States $0.097B 0.00
Ambrx Biopharma (AMAM) United States $0.089B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00